Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on March 8, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print March 8, 2007, doi: 10.1161/ATVBAHA.106.132282
A more recent version of this article appeared on May 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/5/1014    most recent
ATVBAHA.106.132282v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lorenowicz, M. J.
Right arrow Articles by Hordijk, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lorenowicz, M. J.
Right arrow Articles by Hordijk, P. L.

Submitted on October 30, 2006
Accepted on February 15, 2007

cAMP Signaling in Leukocyte Transendothelial Migration

Magdalena J. Lorenowicz ; Mar Fernandez-Borja ; and Peter L. Hordijk *

From the Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, The Netherlands.

* To whom correspondence should be addressed. E-mail: p.hordijk{at}sanquin.nl.

Abstract--The migration of leukocytes across the vascular endothelium is crucial for immunosurveillance as well as for inflammatory responses. Uncontrolled leukocyte transendothelial migration results in pathologies such as asthma, rheumatoid arthritis, and atherosclerosis. The molecular mechanisms that regulate leukocyte transendothelial migration involve signaling downstream of intracellular messengers such as cAMP, calcium, phosphoinositol lipids, or reactive oxygen species. Among these, cAMP is particularly intriguing because it is generated in both leukocytes and endothelial cells and regulates leukocyte chemotaxis as well as endothelial barrier function. In addition, physiological stimuli that induce cAMP production generate both pro- and antiinflammatory signals, underscoring the complexity of cAMP-driven signaling. This review discusses our current knowledge of the control of leukocyte transendothelial migration by two main cAMP effectors: protein kinase A and the Rap exchange factor Epac (Exchange protein directly activated by cAMP).




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. M. Sturm, P. Schratl, R. Schuligoi, V. Konya, G. J. Sturm, I. Th. Lippe, B. A. Peskar, and A. Heinemann
Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors
J. Immunol., November 15, 2008; 181(10): 7273 - 7283.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. R. Paccani, F. D. Molin, M. Benagiano, D. Ladant, M. M. D'Elios, C. Montecucco, and C. T. Baldari
Suppression of T-Lymphocyte Activation and Chemotaxis by the Adenylate Cyclase Toxin of Bordetella pertussis
Infect. Immun., July 1, 2008; 76(7): 2822 - 2832.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, J. J. Zhang, and X.-Y. Huang
cAMP Inhibits Cell Migration by Interfering with Rac-induced Lamellipodium Formation
J. Biol. Chem., May 16, 2008; 283(20): 13799 - 13805.
[Abstract] [Full Text] [PDF]